BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Clinical trials for BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could adding temsirolimus boost chemo for childhood muscle cancer?
Disease control OngoingThis phase 3 trial tests whether adding the drug temsirolimus to standard chemotherapy helps children and young adults with intermediate-risk rhabdomyosarcoma, a type of muscle cancer. About 325 participants receive either standard chemo or standard chemo plus temsirolimus. The s…
Matched conditions: BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug cocktail shows promise against aggressive childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can better control high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer in children and young adults. About 118 participants will receive either the standard treatment or the new combina…
Matched conditions: BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC